Axogen, Inc. (AXGN) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Axogen, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04262-48be-7873-a9a2-b96864933385 Created: 2026-08-27T08:42:16.571Z Duration: 2829.2703 Channels: 1 00:00:00.000 -- 00:00:02.720 Good morning, everyone. Joining me on today's call 00:00:02.720 -- 00:00:05.920 is Michael Dale, Axogen's President and Chief Executive 00:00:05.920 -- 00:00:09.200 Officer Lindsay Hartley, Chief Financial Officer. 00:00:09.679 -- 00:00:12.160 Michael will discuss first quarter twenty twenty six 00:00:12.160 -- 00:00:14.080 financial results and corporate highlights. 00:00:14.424 -- 00:00:17.625 Lindsay will then provide details on financial performance 00:00:17.625 -- 00:00:19.785 and overall outlook for the year. 00:00:20.185 -- 00:00:21.865 This will be followed by a question and 00:00:21.865 -- 00:00:22.744 answer session. 00:00:23.305 -- 00:00:26.345 Today's call and presentation is being broadcast live 00:00:26.345 -- 00:00:28.744 via webcast, which is available on the Investors 00:00:28.744 -- 00:00:30.380 section of Axogen's 00:00:30.380 -- 00:00:32.780 website. Following the end of the live call, 00:00:32.780 -- 00:00:34.860 a replay will be available on the Investors 00:00:34.860 -- 00:00:40.940 section of the company's website at www.axogeninc.com. 00:00:41.660 -- 00:00:43.844 Before we begin, I would like to remind 00:00:43.844 -- 00:00:46.004 you that during this conference call, management will 00:00:46.004 -- 00:00:47.925 be making forward looking statements. 00:00:48.164 -- 00:00:51.445 Forward looking statements include statements regarding financial guidance 00:00:51.445 -- 00:00:55.045 and outlook, clinical development and regulatory efforts, 00:00:55.125 -- 00:00:56.484 commercial growth initiatives, 00:00:56.960 -- 00:00:59.440 reimbursement and market access...